The ACT-Accelerator is a global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
It was launched in April 2020, at an event co-hosted by the Director-General of the World Health Organization, the President of France, the President of the European Commission, and the Bill & Melinda Gates Foundation.
From research to rollout, the ACT-Accelerator remains the world’s only end-to-end solution to end the COVID-19 pandemic.
The partnership comprises the three pillars of Diagnostics, Therapeutics and Vaccines (COVAX), with a cross-cutting Health Systems and Response Connector (HSRC) and Access and Allocation workstream.
Find out more on the Areas of Work page.
The case for investing in the ACT-Accelerator
The co-convening agencies of the ACT-Accelerator are: CEPI, FIND, Gavi, The Global Fund, UNICEF, Unitaid, Wellcome, WHO, the World Bank and The Bill & Melinda Gates Foundation.
Leaders from each of the agencies make up the 'Principals Group', which addresses cross-cutting strategy and delivery considerations, with representatives from industry, CSOs, international financial institutions, and the Facilitation Council invited to participate in meetings.
The ACT-Accelerator Executive Hub, hosted by WHO, plays a central coordination function and aims to facilitate synergies across the partnership. It serves as the secretariat for the Facilitation Council, supporting its meetings as well as those of the Council co-chairs and working groups. The Hub coordinates the Principals Group, as well as hosting and coordinating regular meetings for specific activities across ACT-A partners and pillars, including Communications, Resource Mobilization and CSO engagement. The Hub plays an important role in gathering, synthesizing, and sharing cross-pillar information, developing joint publications and reports on behalf of the ACT-A membership, and collating and publishing the status of funding pledges, via the Commitment Tracker.
There are two WHO Special Envoys for the ACT-Accelerator.
Dr. Ayoade Alakija, Co-Chair of the Africa Union Africa Vaccine Delivery Alliance for COVID-19 (AVDA)
Carl Bildt, former Prime Minister of Sweden and co-chair, European Council on Foreign Relations
The Special Envoys help lead the ACT-Accelerator’s collective advocacy, support the pillar and HSRC leaders, consult widely on the work of the ACT-Accelerator; advise the Director-General, ACT-Accelerator Principals and stakeholders on emerging issues; and represent the ACT-Accelerator in key national and international fora.
The Civil Society Platform (co-led by WACI Health, Global Fund Advocates Network (GFAN) and STOPAIDS) supports community and civil society representatives in the ACT-Accelerator. The platform advocates to ensure every aspect of the ACT-Accelerator has reserved space for communities and civil society to bring their expertise, experience and voices to the COVID-19 response.
The ACT-Accelerator engages with key industry groups, such as the International Federation of Pharmaceutical Manufacturers & Associations (IPFMA), International Generic and Biosimilar Medicines Association (IGBA), and Developing Countries Vaccine Manufacturers Network (DCVMN).